期刊文献+

在体^1H-MR波谱心肌甘油三酯含量检测方法的建立和可重复性研究 被引量:2

The establishment and reproducibility of 1^H-MR spectroscopy in the determination of myocardial triglyceride content in vivo
原文传递
导出
摘要 目的建立^1H-MRS心肌细胞内甘油三酯含量(MTC)的检测方法并进行可重复性研究。方法经常规体检后选取10名健康志愿者,在呼吸门控和心电门控下获得四腔心和短轴面图像以准确定位室间隔,将ROI设定在收缩末期室间隔,应用点分辨波谱(PRESS)序列在呼气末收缩末期由心电图R波激发采集波谱信号,MTC以脂峰下面积与水峰下面积的百分比表示,3个月后重复进行心脏。H—MRS检查以验证该方法的可重复性,以配对t检验比较3个月前后MTC的差异,采用两个变量之间相关性分析MTC和临床特征之间的相关性。结果健康志愿者MTC含量约为(0.46±0.17)%,3个月后(0.48±0.19)%,差异无统计学意义(t=-0.569,P=0.583),MTC和人体学特征如体质量指数[BMI(21.1±2.1)kg/m2,r=0.271,P=0.449]、腰围[(77.9±4.7)cm,r=0.105,P=0.772]、腰臀比(WHR0.81±0.01,r=0.172,P=0.635)、收缩压[SBP(111±16)mmHg(1mmHg=0.133kPa),r=0.267,P=0.456]、舒张压[DBP(71±9)mmHg,r=0.553,P=0.097],空腹血糖[FPG(4.77±0.44)mmol/L,r=0.568,P=0.087]、总胆固醇[TC(4.25±0.55)mmol/L,r=0.067,P=0.854]、甘油三酯[TG(1.07±0.48)mmol/L,r=n478,P=0.162]之间均没有相关性。结论 ^1H-MRS可定量检测心肌细胞内甘油三酯含量,该方法重复性好,可用于临床研究。 Objective To establish the method of 1H-MRS in the determination of myocardial triglyceride content (MTC) in vivo and test its reproducibility. Methods Ten healthy volunteers were recruited after routine physical examination. Cardiac images of the four-chamber and short axis views were collected. Spectroscopic volumes of interest were positioned within the interventricular septum on the endsystolic images. PRESS sequence spectroscopic data acquisition was triggered by electrocardiograph-derived R wave and synchronized with respiratory cycle at end-exhalation. MTC was calculated by the ratio of areas of resonances for lipid and water. After three months 1H-MRS of the heart were conducted again to investigate the reproducibility of the method. MTC before and after three months was compared by using paired t test. The correlation between MTC and clinical data was determined by using correlation analysis. Results MTC in healthy volunteers were ( 0. 46 ±0. 17 ) % and ( 0. 48 ± 0. 19 ) % for the baseline and follow-up respectively. No difference was identified ( t = - 0. 569, P = 0. 583 ). MTC was not correlated with body mass index [ BMI (21.1 ± 2. 1 ) kg/m2, r = 0. 271, P = 0. 4491 , waist circumference [ ( 77.9 ± 4. 7) cm,r = 0. 105,P = 0. 772J, walst-to-hip ratio ( WHR 0. 81 ± 0. 01 ,r = 0. 172,P = 0. 635), systolic blood pressure [ SBP( 111 ± 16) mm Hg ( 1 mm Hg = 0. 133 kPa), r = 0. 267, P = 0. 456 ], diastolic blood pressure [ DBP(71±9) mm Hg,r = -0. 553 ,P = 0. 097], fasting glucose [ FPG(4. 77 ±0.44) mmol/L, r=0.568,P=0.087], total cholesterol [TC(4.25 ± 0.55) mmol/L,r = 0.067, P = 0.854] and triglyceride [TG (1.07±0.48) mmoL/L,r= 0.478,P = 0. 1621. Conclusions Myocardial triglyceride content can be quantitatively determined by 1H-MRS. The reproducibility of myocardial 1H-MRS was good for clinical purpose.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2009年第9期914-917,共4页 Chinese Journal of Radiology
关键词 心肌 甘油三酯类 磁共振波谱学 检测方法 可重复性 Myocardium Triglycerides Magnetic resonance spectroscopy
  • 相关文献

参考文献8

  • 1王南,饶晶晶,董慧,漆剑频.磁共振氢谱和CT在非酒精性脂肪性肝病中的对比应用[J].中华肝脏病杂志,2008,16(7):528-531. 被引量:5
  • 2Szczepaniak LS, Dobbins RL, Metzger GJ, et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med, 2003, 49:417-423.
  • 3国际生命科学学会中国办事处中国肥胖问题工作组.中国成人超重和肥胖症预防与控制指南(试用).北京:中华人民卫生部疾病控制司,2003.
  • 4Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med ,2002,162 : 1867-1872.
  • 5Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes, 1974,23 : 105-111.
  • 6Szczepaniak LS, Victor RG, Orci L,et al. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res,2007 ,101:759-767.
  • 7苏中振,单鸿,何炳钧,吕文天,孟晓春,王劲,朱康顺,杨扬,陈规划.STEAM和PRESS序列在脂肪肝定量诊断中应用价值的对比研究[J].中国介入影像与治疗学,2008,5(2):95-98. 被引量:10
  • 8Li X, Youngren JF, Hyun B, et al. Technical evaluation of in vivo abdominal fat and IMCL quantification using MRI and MRSI at 3 T. Magn Reson Imaging,2008,26:188-197.

二级参考文献19

  • 1潘长玉.代谢综合征认识和防治的新进展——评《国际糖尿病联盟关于代谢综合征定义的全球共识》[J].中华内分泌代谢杂志,2005,21(4):298-300. 被引量:120
  • 2白亮彩,郭顺林,周怀琪,雷军强,窦郁,张毅.1H MRS在定量分析脂肪肝中的初步研究[J].中国医学影像技术,2006,22(4):529-531. 被引量:27
  • 3Mendler MH, Bouillet P, Le Sidaner A, et al. Dual-energy CT in the diagnosis and quantification of fatty liver. limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol, 1998, 28: 785-794.
  • 4Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology, 2007, 244: 479-485.
  • 5Vuppalanchi R, Cummings OW, Saxena R, et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J Clin Gastroenterol, 2007, 41: 206-210.
  • 6Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab, 2005, 288: E462-468.
  • 7Ricci PE, Pitt A, Keller P J, et al. Effect of voxel position on singlevoxel MR spectroscopy findings. AJNR Am J Neuroradiol, 2000, 21: 367-374.
  • 8Schuchmann S, Weigel C, Albrecht L, et al. Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol, 2007, 62: 416-422.
  • 9Marchesini G, Bugianesi E, Fodani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology, 2003, 37: 917-923.
  • 10Thomas EL, Hamilton G, Patel N, et al. Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut, 2005, 54: 122-127.

共引文献13

同被引文献19

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部